These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH. J Infect Dis; 2007 Aug 15; 196(4):608-16. PubMed ID: 17624848 [Abstract] [Full Text] [Related]
5. Vaccination against malaria with live parasites. Rénia L, Grüner AC, Mauduit M, Snounou G. Expert Rev Vaccines; 2006 Aug 15; 5(4):473-81. PubMed ID: 16989628 [Abstract] [Full Text] [Related]
6. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies. Good MF. Trends Immunol; 2005 Jun 15; 26(6):295-7. PubMed ID: 15922944 [Abstract] [Full Text] [Related]
19. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine. Chattopadhyay R, Conteh S, Li M, James ER, Epstein JE, Hoffman SL. Vaccine; 2009 Jun 02; 27(27):3675-80. PubMed ID: 19071177 [Abstract] [Full Text] [Related]
20. Vaccine development against malaria. Matuschewski K. Curr Opin Immunol; 2006 Aug 02; 18(4):449-57. PubMed ID: 16765576 [Abstract] [Full Text] [Related] Page: [Next] [New Search]